Evidence map›Paper›PMID 42875650›Full record

ArticleThe EMBO journal2026

Proximity of pre-mRNA 3' end processing and transcription termination is associated with enhanced gene expression.

Agata Stępień, Deepshika Pulimamidi, Martyna Plens-Gałąska, Maxime Lalonde, Magda Kopczyńska, Klaudia Ostatek, Mariia Kapeliukha, Hiroshi Kimura, Shazia Irshad, Michał R Gdula and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Agata Stępień *Center for Advanced Technologies, Adam Mickiewicz University, 61-614, Poznań, Poland. agata.stepien@amu.edu.pl.ORCID http://orcid.org/0000-0001-9733-7651
Deepshika Pulimamidi *Center for Advanced Technologies, Adam Mickiewicz University, 61-614, Poznań, Poland.ORCID http://orcid.org/0000-0001-7824-7319
Martyna Plens-GałąskaCenter for Advanced Technologies, Adam Mickiewicz University, 61-614, Poznań, Poland.
Maxime LalondeChromosome Dynamics and Genome Stability, Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, 81377, Munich, Germany.ORCID http://orcid.org/0000-0002-0495-8967
Magda KopczyńskaCenter for Advanced Technologies, Adam Mickiewicz University, 61-614, Poznań, Poland.ORCID http://orcid.org/0000-0002-7080-750X
Klaudia OstatekCenter for Advanced Technologies, Adam Mickiewicz University, 61-614, Poznań, Poland.ORCID http://orcid.org/0009-0001-0340-8648
Mariia KapeliukhaCenter for Advanced Technologies, Adam Mickiewicz University, 61-614, Poznań, Poland.
Hiroshi KimuraCell Biology Centre, Institute of Integrated Research, Institute of Science Tokyo, 226-8503, Yokohama, Japan.ORCID http://orcid.org/0000-0003-0854-083X
Shazia IrshadNuffield Department of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, OX3 9DU, Oxford, UK.ORCID http://orcid.org/0000-0003-4536-373X
Michał R GdulaCenter for Advanced Technologies, Adam Mickiewicz University, 61-614, Poznań, Poland.ORCID http://orcid.org/0000-0002-8667-7359
Stephan HamperlChromosome Dynamics and Genome Stability, Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, 81377, Munich, Germany.ORCID http://orcid.org/0000-0002-1658-7948
Kinga Kamieniarz-GdulaCenter for Advanced Technologies, Adam Mickiewicz University, 61-614, Poznań, Poland. kinga.kamieniarz-gdula@amu.edu.pl.ORCID http://orcid.org/0000-0003-3789-5381

Funding

EC | European Research Council (ERC) 852798EC | Horizon Europe | Excellent Science | HORIZON EUROPE European Research Council (ERC) 101042642European Molecular Biology Organization (EMBO) EMBO IG 4728-2020Japan Society for the Promotion of Science (JSPS) KAKENHI(KP24H02325, JP26H02362)Narodowa Agencja Wymiany Akademickiej (NAWA) PPN/PPO/2018/1/00053Narodowe Centrum Nauki (NCN) 2018/30/E/NZ1/00073Narodowe Centrum Nauki (NCN) 2018/31/B/NZ2/04004
6 · The paper itself

Abstract

Two key factors required for pre-mRNA 3' end processing, CPSF73 and PCF11, are linked to poor cancer prognosis, yet their oncogenic roles remain unclear due to their dual function in transcription termination. Using a colorectal cancer (CRC) progression model, we show that primary tumor cells depend on high CPSF73 and PCF11 levels, whereas metastatic cells are less sensitive. This dependency is not explained by alternative polyadenylation (APA) or transcription-replication conflicts. Instead, we identify an uncoupling of 3' cleavage and transcription termination during CRC progression. Primary tumor cells exhibit a global shift toward proximal termination alongside distal APA usage, while metastatic cells partially revert to normal termination patterns and favor proximal APA. Notably, the distance between 3' cleavage and termination is nearly halved in primary tumor cells compared with normal cells and becomes particularly short in oncogenes. Reduced cleavage-termination distance correlates with increased gene expression both within and across cell states. These findings identify a previously unrecognized link between transcription termination architecture and gene expression regulation.

Identifiers

PMID42875650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.